C. Hadigan et al., Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy, CLIN INF D, 32(1), 2001, pp. 130-139
We evaluated metabolic and clinical features of 71 HIV-infected patients wi
th lipodystrophy by comparing them with 213 healthy control subjects, match
ed for age and body mass index, from the Framingham Offspring Study. Thirty
HIV-infected patients without fat redistribution were compared separately
with 90 matched control subjects from the Framingham Offspring Study. Fasti
ng glucose, insulin, and lipid levels; glucose and insulin response to stan
dard oral glucose challenge; and anthropometric measurements were determine
d. HIV-infected patients with lipodystrophy demonstrated significantly incr
eased waist-to-hip ratios, fasting insulin levels, and diastolic blood pres
sure compared with controls. Patients with lipodystrophy were more likely t
o have impaired glucose tolerance, diabetes, hypertriglyceridemia, and redu
ced levels of high-density lipoprotein (HDL) cholesterol than were controls
. With the exception of HDL cholesterol level, these risk factors for cardi
ovascular disease (CVD) were markedly attenuated in patients without lipody
strophy and were not significantly different in comparison with controls. T
hese data demonstrate a metabolic syndrome characterized by profound insuli
n resistance and hyperlipidemia. CVD risk factors are markedly elevated in
HIV-infected patients with fat redistribution.